Task X15: Evaluation of Ebolavirus and Other Filovirus Vaccines in a Novel Animal Model
任务 X15:在新型动物模型中评估埃博拉病毒和其他丝状病毒疫苗
基本信息
- 批准号:9915608
- 负责人:
- 金额:$ 59.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-10-13 至 2020-01-31
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelBiologicalClinicalCommunicable DiseasesContractsDevelopmentEbola VaccinesEbola virusEvaluationFeasibility StudiesFilovirusPhaseSamplingServicesTestingToxicity TestsVaccinesassay developmentefficacy testingevaluation/testingimmunogenicitynovelnovel vaccinesproduct developmentsafety testingtesting servicesvaccine candidate
项目摘要
The Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases contract provides a variety of product development services from early feasibility studies through manufacture of Phase I/II material, including assay development; immunogenicity and efficacy testing; clinical and nonclinical sample testing; and safety and toxicity testing. These services will facilitate the development and introduction of new vaccines and biologics against a wide array of infectious diseases.
传染病疫苗和其他生物制品的评估和测试服务(ETS)合同提供从早期可行性研究到I/II期材料制造的各种产品开发服务,包括分析开发;免疫原性和有效性试验;临床和非临床样品检测;以及安全性和毒性测试。这些服务将促进开发和引进针对各种传染病的新疫苗和生物制剂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RANDI HORNBACK其他文献
RANDI HORNBACK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RANDI HORNBACK', 18)}}的其他基金
TASK X25: Preparedness for Testing NIAID Priority Vaccines in Neurovirulence and Reproductive Toxicology Studies
任务 X25:在神经毒力和生殖毒理学研究中测试 NIAID 优先疫苗的准备
- 批准号:
10017783 - 财政年份:2017
- 资助金额:
$ 59.77万 - 项目类别:
Task X21: Preparedness for Testing NIAID Priority Vaccines in General Safety and Toxicology Studies
任务 X21:在一般安全性和毒理学研究中测试 NIAID 优先疫苗的准备
- 批准号:
10356788 - 财政年份:2017
- 资助金额:
$ 59.77万 - 项目类别:
TASK X23: Control Animal Meta-Analysis for Ebola and Other Filoviruses
任务 X23:埃博拉和其他丝状病毒的对照动物荟萃分析
- 批准号:
9915613 - 财政年份:2017
- 资助金额:
$ 59.77万 - 项目类别:
TASK X25: Preparedness for Testing NIAID Priority Vaccines in Neurovirulence and Reproductive Toxicology Studies
任务 X25:在神经毒力和生殖毒理学研究中测试 NIAID 优先疫苗的准备
- 批准号:
9566491 - 财政年份:2017
- 资助金额:
$ 59.77万 - 项目类别:
Task X21: Preparedness for Testing NIAID Priority Vaccines in General Safety and Toxicology Studies
任务 X21:在一般安全性和毒理学研究中测试 NIAID 优先疫苗的准备
- 批准号:
10251825 - 财政年份:2017
- 资助金额:
$ 59.77万 - 项目类别:
TASK X26: Immunogenicity and Efficacy Testing of Zika Vaccine Candidates in Animal Models
任务 X26:寨卡疫苗候选物在动物模型中的免疫原性和功效测试
- 批准号:
10161666 - 财政年份:2017
- 资助金额:
$ 59.77万 - 项目类别:
TASK X22: Non-GLP Safety Study of multivalent toxoid S. aureus Vaccine (IBT-V02) in nonhuman primates for Integrated Biotherapeutics
任务 X22:用于综合生物治疗的多价类毒素金黄色葡萄球菌疫苗 (IBT-V02) 在非人灵长类动物中的非 GLP 安全性研究
- 批准号:
9537826 - 财政年份:2017
- 资助金额:
$ 59.77万 - 项目类别:
Task X17: Malaria Vaccine Safety and Toxicology Studies
任务 X17:疟疾疫苗安全性和毒理学研究
- 批准号:
9430327 - 财政年份:2016
- 资助金额:
$ 59.77万 - 项目类别:
Task X19: Development of Assays and Reagents for Zika Virus Vaccines
任务 X19:寨卡病毒疫苗检测方法和试剂的开发
- 批准号:
9915594 - 财政年份:2016
- 资助金额:
$ 59.77万 - 项目类别:
Task X17: Malaria Vaccine Safety and Toxicology Studies
任务 X17:疟疾疫苗安全性和毒理学研究
- 批准号:
10074438 - 财政年份:2016
- 资助金额:
$ 59.77万 - 项目类别:
相似海外基金
THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE
NNTC 收集、存储和提供临床数据和特征明确的生物样本,包括来自研究志愿者和/或艾滋病毒感染者和艾滋病毒阴性者的器官捐献者的死后组织
- 批准号:
10934920 - 财政年份:2023
- 资助金额:
$ 59.77万 - 项目类别:
THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE
NNTC 收集、存储和提供临床数据和特征明确的生物样本,包括来自研究志愿者和/或艾滋病毒感染者和艾滋病毒阴性者的器官捐献者的死后组织
- 批准号:
10934926 - 财政年份:2023
- 资助金额:
$ 59.77万 - 项目类别:
THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE
NNTC 收集、存储和提供临床数据和特征明确的生物样本,包括来自研究志愿者和/或艾滋病毒感染者和艾滋病毒阴性者的器官捐献者的死后组织
- 批准号:
10945539 - 财政年份:2023
- 资助金额:
$ 59.77万 - 项目类别:
THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE
NNTC 收集、存储和提供临床数据和特征明确的生物样本,包括来自研究志愿者和/或艾滋病毒感染者和艾滋病毒阴性者的器官捐献者的死后组织
- 批准号:
10934927 - 财政年份:2023
- 资助金额:
$ 59.77万 - 项目类别:
THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE
NNTC 收集、存储和提供临床数据和特征明确的生物样本,包括来自研究志愿者和/或艾滋病毒感染者和艾滋病毒阴性者的器官捐献者的死后组织
- 批准号:
10945543 - 财政年份:2023
- 资助金额:
$ 59.77万 - 项目类别:
BIOLOGICAL TESTING FACILITY - DISCOVERY, CLINICAL FORMULATION, AND MANUFACTURE OF CONTRACEPTIVES
生物测试设施 - 避孕药具的发现、临床配方和制造
- 批准号:
10923031 - 财政年份:2023
- 资助金额:
$ 59.77万 - 项目类别:
THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE
NNTC 收集、存储和提供临床数据和特征明确的生物样本,包括来自研究志愿者和/或艾滋病毒感染者和艾滋病毒阴性者的器官捐献者的死后组织
- 批准号:
10934921 - 财政年份:2023
- 资助金额:
$ 59.77万 - 项目类别:
Quantification of histological intratumor heterogeneity in lung cancer and, its biological and clinical significance.
肺癌组织学瘤内异质性的量化及其生物学和临床意义。
- 批准号:
23K14494 - 财政年份:2023
- 资助金额:
$ 59.77万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE
NNTC 收集、存储和提供临床数据和特征明确的生物样本,包括来自研究志愿者和/或艾滋病毒感染者和艾滋病毒阴性者的器官捐献者的死后组织
- 批准号:
10938107 - 财政年份:2023
- 资助金额:
$ 59.77万 - 项目类别:
THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE
NNTC 收集、存储和提供临床数据和特征明确的生物样本,包括来自研究志愿者和/或艾滋病毒感染者和艾滋病毒阴性者的器官捐献者的死后组织
- 批准号:
10948479 - 财政年份:2023
- 资助金额:
$ 59.77万 - 项目类别:














{{item.name}}会员




